Other results also suggest that GLP-1 increases ER-mitochondria communication in vascular smooth muscle cells, resulting in higher mitochondrial activity 76
2017 Oct;1863(10 Pt A):2414-2435
Entry point for public reimbursement Using the reduced off-patent price as a strong argument for increased access, Canada could become the first market with wide-scale reimbursement of existing primary care medicines, including GLP-1s for diabetes, to designate off-patent semaglutide as the first-line anti-obesity medication (AOM)
144 LiuW.YamashitaT.TianF.MorimotoN.IkedaY.DeguchiK.et al (2013)
[There is] difficulty in achieving weight loss in patients with obesity and asthma, which is often made worse by the need for oral steroids to treat flare ups of asthma, Professor Alan Kaplan, chairperson of the Family Physician Airways Group of Canada and the Observational and Pragmatic Research Institute, told Technology Networks